New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - indinavir sulfate 250mg equivalent to 200 mg indinavir;  ;   - capsule - 200 mg - active: indinavir sulfate 250mg equivalent to 200 mg indinavir     excipient: gelatin lactose magnesium stearate tekprint blue sb-6018 - indicated for the treatment of adults with hiv-1 infection. clinical studies demonstrated: · reduced risk of progression to an aids-defining illness or death · increased overall survival · durable reduction in serum viral rna · durable increase in cd4 cell counts

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - indinavir sulfate 500mg equivalent to 400 mg indinavir;  ;   - capsule - 400 mg - active: indinavir sulfate 500mg equivalent to 400 mg indinavir     excipient: gelatin lactose magnesium stearate tekprint green sb-4020 - indicated for the treatment of adults with hiv-1 infection. clinical studies demonstrated: · reduced risk of progression to an aids-defining illness or death · increased overall survival · durable reduction in serum viral rna · durable increase in cd4 cell counts

United States - English - NLM (National Library of Medicine)

rebel distributors corp - indinavir sulfate (unii: 771h53976q) (indinavir - unii:5w6ya9pkkh) - indinavir 400 mg - crixivan in combination with antiretroviral agents is indicated for the treatment of hiv infection. this indication is based on two clinical trials of approximately 1 year duration that demonstrated: 1) a reduction in the risk of aids-defining illnesses or death; 2) a prolonged suppression of hiv rna. in all clinical studies, with the exception of actg 320, the amplicor hiv monitor assay was used to determine the level of circulating hiv rna in serum. this is an experimental use of the assay. hiv rna results should not be directly compared to results from other trials using different hiv rna assays or using other sample sources. study actg 320 was a multicenter, randomized, double-blind clinical endpoint trial to compare the effect of crixivan in combination with zidovudine and lamivudine with that of zidovudine plus lamivudine on the progression to an aids-defining illness (adi) or death. patients were protease inhibitor and lamivudine naive and zidovudine experienced, with cd4 cell counts of ≤200 cells/mm3

United States - English - NLM (National Library of Medicine)

state of florida doh central pharmacy - indinavir sulfate (unii: 771h53976q) (indinavir - unii:5w6ya9pkkh) - indinavir 400 mg - crixivan in combination with antiretroviral agents is indicated for the treatment of hiv infection. this indication is based on two clinical trials of approximately 1 year duration that demonstrated: 1) a reduction in the risk of aids-defining illnesses or death; 2) a prolonged suppression of hiv rna. in all clinical studies, with the exception of actg 320, the amplicor hiv monitor assay was used to determine the level of circulating hiv rna in serum. this is an experimental use of the assay. hiv rna results should not be directly compared to results from other trials using different hiv rna assays or using other sample sources. study actg 320 was a multicenter, randomized, double-blind clinical endpoint trial to compare the effect of crixivan in combination with zidovudine and lamivudine with that of zidovudine plus lamivudine on the progression to an aids-defining illness (adi) or death. patients were protease inhibitor and lamivudine naive and zidovudine experienced, with cd4 cell counts of ≤200 cells/mm3

United States - English - NLM (National Library of Medicine)

stat rx usa llc - indinavir sulfate (unii: 771h53976q) (indinavir anhydrous - unii:9mg78x43zt) - indinavir anhydrous 400 mg - crixivan in combination with antiretroviral agents is indicated for the treatment of hiv infection. this indication is based on two clinical trials of approximately 1 year duration that demonstrated: 1) a reduction in the risk of aids-defining illnesses or death; 2) a prolonged suppression of hiv rna. in all clinical studies, with the exception of actg 320, the amplicor hiv monitor assay was used to determine the level of circulating hiv rna in serum. this is an experimental use of the assay. hiv rna results should not be directly compared to results from other trials using different hiv rna assays or using other sample sources. study actg 320 was a multicenter, randomized, double-blind clinical endpoint trial to compare the effect of crixivan in combination with zidovudine and lamivudine with that of zidovudine plus lamivudine on the progression to an aids-defining illness (adi) or death. patients were protease inhibitor and lamivudine naive and zidovudine experienced, with cd4 cell counts of ≤200 cells/mm3

United States - English - NLM (National Library of Medicine)

merck sharp & dohme corp. - indinavir sulfate (unii: 771h53976q) (indinavir anhydrous - unii:9mg78x43zt) - indinavir anhydrous 100 mg - crixivan in combination with antiretroviral agents is indicated for the treatment of hiv infection. this indication is based on two clinical trials of approximately 1 year duration that demonstrated: 1) a reduction in the risk of aids-defining illnesses or death; 2) a prolonged suppression of hiv rna. in all clinical studies, with the exception of actg 320, the amplicor hiv monitor assay was used to determine the level of circulating hiv rna in serum. this is an experimental use of the assay. hiv rna results should not be directly compared to results from other trials using different hiv rna assays or using other sample sources. study actg 320 was a multicenter, randomized, double-blind clinical endpoint trial to compare the effect of crixivan in combination with zidovudine and lamivudine with that of zidovudine plus lamivudine on the progression to an aids-defining illness (adi) or death. patients were protease inhibitor and lamivudine naive and zidovudine experienced, with cd4 cell counts of ≤200 cells/mm3

United States - English - NLM (National Library of Medicine)

avera mckennan hospital - indinavir sulfate (unii: 771h53976q) (indinavir anhydrous - unii:9mg78x43zt) - indinavir anhydrous 400 mg

Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - indinavir sulphate eqv indinavir - capsule - 200 mg - indinavir sulphate eqv indinavir 200 mg

Canada - English - Health Canada

merck canada inc - indinavir (indinavir sulfate) - capsule - 200mg - indinavir (indinavir sulfate) 200mg - hiv protease inhibitors

Canada - English - Health Canada

merck canada inc - indinavir (indinavir sulfate) - capsule - 300mg - indinavir (indinavir sulfate) 300mg - hiv protease inhibitors